R
Reprieve Cardiovascular
Health Tech & Medtech · Milford, United States · Founded 2018
Led by a seasoned management team with extensive experience in the medical device industry MoreLess
Reprieve Cardiovascular is a medical device company that develops and commercializes therapies for fluid management in patients suffering from acute decompensated heart failure (ADHF).
The company's core offering is a personalized decongestion management system that automates the management of a patient's fluid levels. This system is designed to enable clinicians to remove excess fluid from patients with ADHF safely and effectively.
Reprieve Cardiovascular operates in the cardiovascular medical device market, targeting a patient population of over 25 million individuals with heart failure globally. The company's business model is centered on the development and sale of its proprietary medical devices to hospitals and other healthcare facilities that treat acute heart failure.
Keywords: medical devices, acute decompensated heart failure, fluid management, cardiovascular, decongestion, therapies, healthcare, life sciences, medical equipment, healthtech
Talent graph
Reprieve Cardiovascular's talent
Source: Dealroom Talent Intelligence.
Investors
8 investors on Reprieve Cardiovascular's cap table
Sourced from Dealroom's funding history.
Global footprint
Where Reprieve Cardiovascular has talent and traffic
team presence
Market sentiment
What the market is saying about Reprieve Cardiovascular
An AI-synthesized read of the highest-engagement posts about Reprieve Cardiovascular on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Reprieve Cardiovascular on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.